department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

ASTRAZENECA · pharmadog

PUBLIC COMPANY

ASTRAZENECA

USupdated 2mo ago

community read0 votes

pipeline

0

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(0)

no pipeline products on record

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view ASTRAZENECA jobs →

News

no news has mentioned this company yet

identifiers

country

US

source

openfda_drugsfda

mentioned in

0news items

entity-linker matched

Active trials

phase3A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronismrecruitingn=250
phase3Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)completedn=2,187
—A Prospecitve Multicenter, Observational Registry Studyrecruitingn=3,000
phase2This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweightactive not recruitingn=14
phase2A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Diseaserecruitingn=43
phase2Study of AZD9829 in CD123+ Hematological Malignanciescompletedn=56
phase1The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.active not recruitingn=7
phase3Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterationsrecruitingn=400

more trials →

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?